Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05261269 |
|---|---|
| Brief Title: | A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer |
| First Submitted : | February 15, 2022 |
| First Submitted that Met QC Criteria : | February 25, 2022 |
| First Posted : | March 2, 2022 |
| Last Update Submitted that Met QC Criteria : | January 17, 2023 |
| Last Update Posted : | January 18, 2023 |